The days of taking pills designed for a one-size-fits-all approach may soon be at an end. Here’s a look at the future of medicine. Here’s a word you’ll likely being hearing a lot more; pharmacogenomics. So what does it mean? Essentially, it is tailoring a drug medicine to your particular genetics. This could be everything from cholesterol medications through to antidepressants or blood thinners. The word combines pharmaceuticals and genomics. In this fairly new field, doctors look at two main things; 1) how much of a drug is needed to hit the target in your body and 2) how well the targeted cells, such as heart tissue or neurons in your body will respond to a specific dosage. While this has been in development for decades, the cost of sequencing a genome has been so high it wasn’t commercially viable at scale. With the advances in CRISPR technology, the costs